Does Rallies show 13F holders for ENTX?

Yes. Rallies tracks hedge fund and 13F ownership data for ENTX, including fund names, share counts, latest tracked quarter, and position changes when available.

Is ENTX research on Rallies investment advice?

No. Rallies provides research, data, and educational context for ENTX. It does not provide personalized investment advice.

ENTX (Entera Bio Ltd. Ordinary Shares) Stock Analysis - Hedge Fund Holdings

Entera Bio Ltd. Ordinary Shares (ENTX) is a publicly traded Healthcare sector company. As of May 21, 2026, ENTX trades at $1.23 with a market cap of $60.55M and a P/E ratio of 4.97. ENTX moved +0.00% today. Year to date, ENTX is -29.94%; over the trailing twelve months it is -39.81%. Its 52-week range spans $0.91 to $3.22. Analyst consensus is buy with an average price target of $9.00. Rallies surfaces ENTX's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.

Who owns ENTX stock?

Hedge funds tracked by Rallies that own ENTX include Renaissance Technologies and Citadel Advisors. The latest tracked quarter is Dec 31, 2024. Rallies shows current holdings, share counts, position changes, and 13F ownership context for Entera Bio Ltd. Ordinary Shares.

ENTX Key Metrics

Key financial metrics for ENTX
Metric	Value
Price	$1.23
Market Cap	$60.55M
P/E Ratio	4.97
EPS	$0.25
Dividend Yield	0.00%
52-Week High	$3.22
52-Week Low	$0.91
Volume	0
Avg Volume	0
Revenue (TTM)	$42.00K
Net Income	$-11.44M
Gross Margin	0.00%

Top Hedge Funds Holding ENTX

Renaissance Technologies holds 61.80K shares of ENTX, changed +0.98% as of Dec 31, 2024.
Citadel Advisors holds 20.55K shares of ENTX, changed +64.40% as of Sep 30, 2024.

Latest ENTX News

Entera Bio Eyes H2 2028 Topline with 750-Patient Phase 3 EB613 Trial — Mar 27, 2026
Entera Bio Chairman and Three Directors Buy Shares After CEO December Purchase — Feb 11, 2026
Entera Bio Names Ex-Pfizer Leader Germano Chairman Ahead of Phase 3 EB613 Launch — Feb 9, 2026

Recent ENTX Insider Trades

Germano Geno J bought 20.00K (~$26.00K) on Mar 9, 2026.
Ellis Sean bought 10.00K (~$12.30K) on Mar 5, 2026.
Taitel Haya bought 7.50K (~$11.10K) on Feb 10, 2026.

ENTX Analyst Consensus

1 analysts cover ENTX: 0 strong buy, 1 buy, 0 hold, 0 sell, 0 strong sell. Consensus rating is buy. Average price target: $9.00.

Common questions about ENTX

Who owns ENTX stock?: Hedge funds tracked by Rallies that own ENTX include Renaissance Technologies and Citadel Advisors. The latest tracked quarter is Dec 31, 2024. Rallies shows current holdings, share counts, position changes, and 13F ownership context for Entera Bio Ltd. Ordinary Shares.
Does Rallies show 13F holders for ENTX?: Yes. Rallies tracks hedge fund and 13F ownership data for ENTX, including fund names, share counts, latest tracked quarter, and position changes when available.
Is ENTX research on Rallies investment advice?: No. Rallies provides research, data, and educational context for ENTX. It does not provide personalized investment advice.